Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System
Recruiting
Observational Study
Total Hip Arthroplasty (THA)
Hemiarthroplasty
Osteoarthritis (OA) of the Hip
Femoral Neck Fractures
Joint Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 101 (estimated)
- Sponsor
- TIPMED Medical Device Manufacturing Ltd. Co. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcome…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals aged 18 years and older,
* Male or female participants,
* Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,
* Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.
*…
Contacts